Friday, July 10, 2026

Drug profile · INN

sodium fluoride f-18

sodium fluoride f-18 (SODIUM FLUORIDE F-18) is an FDA-listed pharmaceutical active ingredient. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.

FDA: approved
US status approved
Patents linked 0
Pipeline programs 0
News articles 0
Drug details — sodium fluoride f-18
US status
approved
Class
Route
INTRAVENOUS
Patents
0
Programs
0
Data quality
0.89

Quick answer

sodium fluoride f-18 (SODIUM FLUORIDE F-18) is an FDA-listed pharmaceutical active ingredient. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.

Key facts

INN sodium fluoride f-18
Brand SODIUM FLUORIDE F-18
Route INTRAVENOUS
Formulation INJECTABLE

Approval history

Authority Status Date
FDA approved

Frequently asked questions

What is sodium fluoride f-18?

sodium fluoride f-18 (SODIUM FLUORIDE F-18) is an FDA-listed pharmaceutical active ingredient. Associated with Chongqing Precision Biotech Co., Ltd. Route of administration: intravenous. Current US regulatory status: approved.

What is the brand name for sodium fluoride f-18?

SODIUM FLUORIDE F-18 is a marketed brand name for sodium fluoride f-18. Check FDA Drugs@FDA for the current US label holder and prescribing information.

What is the US approval status of sodium fluoride f-18?

sodium fluoride f-18 has approved status in the United States according to our Drugs@FDA-derived records. Verify on the official FDA label before clinical or commercial decisions.